piracetam has been researched along with Fatigue Syndrome, Chronic in 2 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Fatigue Syndrome, Chronic: A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We studied efficacy and tolerability of the combined drug omaron (25 mg of cinnarizine and 400 mg of piracetam in one tablet) in patients with multiple sclerosis." | 5.14 | [Omaron in the complex treatment of patients with multiple sclerosis]. ( Batysheva, TT; Boĭko, AN; Kamchatnov, PR; Popova, NF; Riabukhina, OV; Zaĭtsev, KA, 2010) |
| "In patients with encephalopathies, chronic fatigue syndrome was directly associated with the severity of depression." | 2.73 | Characteristics of the formation of chronic fatigue syndrome and approaches to its treatment in young patients with focal brain damage. ( Batysheva, TT; Boiko, AN; Gusev, EI; Manevich, TM; Matvievskaya, OV, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Popova, NF | 1 |
| Kamchatnov, PR | 1 |
| Riabukhina, OV | 1 |
| Batysheva, TT | 2 |
| Zaĭtsev, KA | 1 |
| Boĭko, AN | 2 |
| Matvievskaya, OV | 1 |
| Manevich, TM | 1 |
| Gusev, EI | 1 |
2 trials available for piracetam and Fatigue Syndrome, Chronic
| Article | Year |
|---|---|
[Omaron in the complex treatment of patients with multiple sclerosis].
Topics: Adult; Cinnarizine; Drug Combinations; Fatigue Syndrome, Chronic; Female; Humans; Male; Middle Aged; | 2010 |
Characteristics of the formation of chronic fatigue syndrome and approaches to its treatment in young patients with focal brain damage.
Topics: Adult; Brain Injuries; Calcium Channel Blockers; Cinnarizine; Drug Therapy, Combination; Fatigue Syn | 2007 |